Patient and procedural characteristics
PV isolation was successfully completed in all 1004 cases, using Carto 3 in 822 (82%), Ensite NavX in 159 (16%) and Rhythmia in 23 (2%). Patient characteristics are shown in Table 1. Procedural characteristics between patients with and without DHF are shown in Supplementary Table 1.